Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
about
Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Serum miR-22 as potential non- ...... a: an explorative pilot study.
@en
Serum miR-22 as potential non- ...... a: an explorative pilot study.
@nl
type
label
Serum miR-22 as potential non- ...... a: an explorative pilot study.
@en
Serum miR-22 as potential non- ...... a: an explorative pilot study.
@nl
prefLabel
Serum miR-22 as potential non- ...... a: an explorative pilot study.
@en
Serum miR-22 as potential non- ...... a: an explorative pilot study.
@nl
P2093
P2860
P50
P1476
Serum miR-22 as potential non- ...... ma: an explorative pilot study
@en
P2093
Andrea Mengarelli
Anna Di Benedetto
Cristiana Ercolani
Francesca Palombi
Giovanni Blandino
Giulia Regazzo
Irene Terrenato
Maria Giulia Rizzo
Sara Donzelli
P2860
P2888
P356
10.1186/S13046-018-0768-5
P577
2018-05-02T00:00:00Z
P6179
1103745258